Accessibility Menu
 
Pulmatrix logo

Pulmatrix

(NASDAQ) PULM

Current Price$1.27
Market Cap$4.71M
Since IPO (2015)-100%
5 Year-93%
1 Year-80%
1 Month-2%

Pulmatrix Financials at a Glance

Market Cap

$4.71M

Revenue (TTM)

$0.00

Net Income (TTM)

$5.16M

EPS (TTM)

$-1.41

P/E Ratio

-0.91

Dividend

$0.00

Beta (Volatility)

0.49 (Low)

Price

$1.27

Volume

10

Open

$1.27

Previous Close

$1.27

Daily Range

$1.27 - $1.27

52-Week Range

$1.16 - $9.37

PULM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pulmatrix

Industry

Pharmaceuticals

Employees

2

CEO

Peter B. Ludlum, MBA

Headquarters

Lexington, MA 02421, US

PULM Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-81%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-1.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.71M

Shares Outstanding

3.65M

Volume

10

Avg. Volume

49.73K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.17M

EBITDA

$5.16M

Operating Cash Flow

$5.43M

Capital Expenditure

$0.00

Free Cash Flow

$5.43M

Cash & ST Invst.

$4.09M

Total Debt

$0.00

Pulmatrix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.71M

N/A

Market Cap/Employee

$2.36M

N/A

Employees

2

N/A

Net Income

$928.00K

+53.3%

EBITDA

$928.00K

+52.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.09M

-57.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.25%

N/A

Return on Invested Capital

-1.36%

N/A

Free Cash Flow

$706.00K

+44.0%

Operating Cash Flow

$706.00K

+44.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FBLGFibroBiologics, Inc. Common Stock
$1.46+10.61%
CRISCuris, Inc.
$0.59-1.33%
CTXRCitius Pharmaceuticals, Inc.
$0.70+0.57%
ASBPAspire Biopharma Holdings, Inc.
$0.21-4.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About PULM

What is the current price of Pulmatrix?

Pulmatrix is trading at $1.27 per share.

What is the 52-week range for Pulmatrix?

Over the past 52 weeks, Pulmatrix has traded between $1.16 and $9.37.

How much debt does Pulmatrix have?

As of the most recent reporting period, Pulmatrix reported total debt of N/A.

How much cash does Pulmatrix have on hand?

Pulmatrix reported $4.09M in cash and cash equivalents in its most recent financial results.

What is Pulmatrix’s dividend yield?

Pulmatrix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.